Magenta Therapeutics (MGTA) Highlights Final Phase 1 Results of MGTA-145 Stem Cell Mobilization Clinical Trial and Preclinical Data from Targeted Conditioning Program at EBMT 2021 Meetings
- Dow hits record, cyclicals rise on jobless claims data
- PayPal (PYPL) Gains After Topping Q1 and Guidance Expectations, Crypto Seen as a Key Growth Driver Going Forward
- Fed's Kaplan wants taper talk 'sooner rather than later'
- U.S. weekly jobless claims drop below 500,000; layoffs lowest since 2000
- Uber (UBER) Falls After Missing on Revenue Expectations, Analysts Lower PTs on Regulatory and Driver Supply Concerns